47
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3624 |
A-366
A 366,A366 |
Epigenetic Reader Domain; Histone Methyltransferase | Chromatin/Epigenetic |
A-366 是一种高选择性的肽竞争性组蛋白甲基转移酶 G9a 抑制剂,对 G9a 和 GLP 的 IC50分别为 3.3 和 38 nM。它比其他 21 种甲基转移酶具有 1000 倍以上的选择性。它是 Spindlin1-H3K4me3相互作用的抑制剂,IC50为182.6 nM。它对人 H3R 表现出很高的亲和力,Ki 值为 17 nM,在组胺能和多巴胺能受体家族的亚群间表现出亚型选择性。 | |||
T26645 |
Aptiganel
CNS 1102,CNS-1102,CNS1102 |
NMDAR | Neuroscience |
Aptiganel (CNS-1102) 是一种非竞争性 NMDA 拮抗剂,是一种多肽,可用于研究急性缺血性卒中。 | |||
TP2100 |
Avexitide
Exendin-3 (9-39) amide,Exendin (9-39),艾塞那肽 |
Glucagon Receptor | GPCR/G Protein |
Avexitide (Exendin-3 (9-39) amide) 是一种特异竞争性的glucagon-like peptide-1 (GLP-1)受体拮抗剂。 | |||
TP1523 |
PKG inhibitor peptide TFA (82801-73-8 free base)
PKG inhibitor peptide TFA |
PKA | Tyrosine Kinase/Adaptors |
PKG inhibitor peptide TFA (82801-73-8 free base) 是 ATP 竞争性 cGMP 依赖性蛋白激酶 (PKG) 的抑制剂。 | |||
TP2103L |
[D-p-Cl-Phe6,Leu17]-VIP acetate
|
Others | Others |
[D-p-Cl-Phe6,Leu17]-VIP acetate 是一种竞争性和选择性的血管活性肠肽 (VIP) 受体拮抗剂 (IC50 = 125.8 nM)。 | |||
T78223 |
γ-Glu-Tyr
gamma-Glutamyltyrosine,gamma-GLU-TYR |
||
γ-Glu-Tyr (gamma-Glutamyltyrosine) 是一种对二肽基肽酶-IV (DPP-IV) 具有竞争性抑制作用的 kokumi 肽,可用于研究糖尿病。 | |||
T15387 | GLP-1R Antagonist 1 | Glucagon Receptor | GPCR/G Protein |
GLP-1R Antagonist 1 (compound 5d) 是口服有效的、能透过中枢神经系统的,胰高血糖素样肽 1 受体 (GLP-1R) 的非竞争性抑制,其 IC50 值为 650 nM。 | |||
TP1887L1 |
[Ala107]-MBP (104-118) acetate
[Ala107]-MBP (104-118) acetate(99026-77-4 free base) |
PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
[Ala107]-MBP (104-118) acetate ([Ala107]-MBP )(99026-77-4 free base) 是牛髓鞘碱性蛋白 (MBP) 的合成肽类似物。 PKC 的非竞争性抑制剂 (IC50 = 46 - 145 mM)。 | |||
TP1785L |
Peptide T acetate(106362-32-7 free base)
|
Others; HIV Protease | Microbiology/Virology; Others; Proteases/Proteasome |
Peptide T acetate(106362-32-7 free base) 是一种来自 HIV-1 gp120 V2 区域的八肽。它是一种合成八肽,其可能的作用机制是 gp120 对 CD4 受体的竞争性抑制以及与血管肠肽受体的结合和抑制细胞因子作用。 | |||
TP1890L1 |
MLCK inhibitor peptide 18 acetate
MLCK inhibitor peptide 18 acetate(224579-74-2 free base) |
Serine/threonin kinase | Cell Cycle/Checkpoint; Metabolism |
MLCK inhibitor peptide 18 acetate(224579-74-2 free base) 是肌球蛋白轻链激酶的选择性竞争性抑制剂 (IC50 = 50 nM)。显示出比 CaM 激酶 II 高 4000 倍的选择性,并且不抑制 PKA。细胞可渗透。 | |||
T8313 |
HCH6-1
|
Others | Others |
HCH6-1 是甲酰肽受体 1 的竞争性二肽拮抗剂。它能够抑制 fMLF (FPR1激动剂) 特异性激活的人中性粒细胞的趋化性、超氧阴离子生成和弹性酶释放。动物实验中,它对急性肺损伤具有保护作用,可用于研究 FPR1 参与的炎症性肺部疾病。 | |||
T8691 |
PD 168368
PD168368 |
Bombesin Receptor | GPCR/G Protein |
PD 168368 是一种新型有效且具有竞争性和选择性的非肽类神经调节蛋白 B 受体 (NMB-R) 拮抗剂,对胃泌素释放肽受体 (GRPR)具有抑制作用。PD 168368 是一种高效的 FPR1/FPR2/FPR3 的混合激动剂。 | |||
T71280 |
S 8308
|
||
S 8308 is a weak, but specific and competitive, non-peptide antagonist of AII exerting its inhibitory action at the receptor level. | |||
T69621 |
BIIE-0246 HCl
|
||
BIIE-0246 is a potent, selective and competitive non-peptide antagonist for the neuropeptide Y Y2 receptor. BIIE-0246 displays > 650-fold selectivity over Y1, Y4 and Y5 receptors. | |||
T17281 |
Z-Ile-Leu-aldehyde
Z-IL-CHO,GSI-XII,γ-Secretase inhibitor XII |
Others | Others |
Z-Ile-Leu-aldehyde is an effective and competitive peptide aldehyde inhibitor of γ-secretase and notch. | |||
TP1888 |
[Ala113]MBP(104-118)
[Ala113]-MBP (104-118) |
||
Synthetic peptide analog of bovine myelin basic protein (MBP). Non-competitive inhibitor of PKC (IC50 = 28 - 62 mM). | |||
T81448 |
PKG inhibitor peptide TFA
|
||
PKG inhibitor peptide TFA 是 ATP 竞争性抑制剂,具有 86 μM 的Ki值。 | |||
TP1887 |
[Ala107]MBP(104-118)
[Ala107]-MBP (104-118) |
||
Synthetic peptide analog of bovine myelin basic protein (MBP). Non-competitive inhibitor of PKC (IC50 = 46 - 145 mM). | |||
TP1785 |
Peptide T
|
||
Peptide T is an octapeptide from the V2 region of HIV-1 gp120. Peptide T is a synthetic octapeptide whose possible mechanism of action is the competitive inhibition of gp120 to the CD4 receptor as well as binding to vasointestinal peptide receptors and in | |||
T38460 |
SN52
|
||
SN52 is a powerful, competitive, and cell-permeable inhibitor of NF-κB2. It is a variant of the SN50 peptide. SN52 effectively prevents the nuclear translocation of p52-RelB heterodimers, exhibiting a robust radiosensitization effect on prostate cancer cells. This compound holds significant potential for cancer research purposes. | |||
T60319 |
AZ8838
|
||
AZ8838 是一种有效的、竞争性的、变构的、口服活性的 PAR2非肽小分子拮抗剂,其对 hPAR2 的 pKi 值为 6.4。 | |||
T68192 | OK-1035 | ||
OK-1035 is a potent and selective DNA-PK inhibitor. When a synthetic peptide was used as a substrate, OK-1035 caused 50% inhibition of DNA-PK activity at 8 microM. OK-1035 inhibited the phosphorylation by DNA-PK of consensus peptide as well as that of recombinant human wild type-p53. Kinetic studies indicated that OK-1035 inhibited DNA-PK activity in an ATP-competitive manner. | |||
T70837 | Rimegepant sulfate hydrate | ||
Rimegepant, also known as BMS-927711 and BHV-3000, is a potent, selective, competitive, and orally active calcitonin gene-related peptide (CGRP) antagonist in clinical trials for treating migraines. Rimegepant has shown in vivo efficacy without vasoconstriction effect. BMS-927711 is superior to placebo at several different doses (75 mg, 150 mg, and 300 mg) and has an excellent tolerability profile. | |||
T81817 |
Met-Arg-Phe-Ala
|
||
Met-Arg-Phe-Ala为一种肽类化合物,同时作为脑啡肽生成内肽酶(EGE)的有效竞争性抑制剂,应用于神经系统疾病的研究。 | |||
TP1903 |
PKG inhibitor peptide
cGMP Dependent Kinase Inhibitor Peptide |
||
Competitive inhibitor of cGMP-dependent protein kinase (PKG); analog of a substrate peptide corresponding to a phosphorylation site of histone H2B. Competes with synthetic substrates (Ki = 86 mM) but does not inhibit phosphorylation of intact histones by | |||
T15415 |
GR 159897
|
Others | Others |
GR 159897 is a competitive, brain-penetrated non-peptide NK2 receptor antagonist with anti-tumor effects. GR 159897 inhibits binding of [3H]GR100679 to human NK2-CHO cells and rat colon membranes (pKis: 9.51 and 10, respectively). It can antagonize bronch | |||
T41062 |
HXR9
|
||
HXR9 is a cell-permeable peptide that acts as a competitive antagonist of the HOX/PBX interaction. It effectively inhibits the binding between HOX proteins and the transcription factor PBX, specifically in paralogue groups 1 to 8. HXR9 selectively impairs cell proliferation and induces apoptosis in cells with a high expression of the HOXA/PBX3 genes, for instance, MLL-rearranged leukemic cells. | |||
T75878 |
Catestatin TFA
|
||
Catestatin TFA,一个含有21个氨基酸残基、阳离子性疏水性肽,作为内源性肽,调节心脏功能及血压。它通过烟碱型乙酰胆碱受体(nAChRs)以非竞争性方式抑制儿茶酚胺释放,功能为烟碱类拮抗剂。 | |||
T32004 |
GSK172981
GSK 172981,GSK-172981 |
||
GSK172981 is a non-peptide tachykinin NK3 receptor antagonist with a high affinity for the recombinant human (PK (I) value 7.7) and native guinea pig (PK (I) value 7.8) tachykinin NK3 receptor. In vitro, the functional evaluation showed that GSK172981 was | |||
T62039 | L-365260 hemihydrate | ||
L-365260 hemihydrate 是选择性的、具有口服活性的非肽胃泌素和脑胆囊收缩素受体 (CCK-B) 拮抗剂,Kis 值分别为 1.9 nM 和 2.0 nM。L-365260 hemihydrate 以竞争性方式与豚鼠胃泌素和脑 CCK 受体相互作用。 | |||
T78003 |
[D-p-Cl-Phe6,Leu17]-VIP TFA
|
||
[D-p-Cl-Phe6,Leu17]-VIP TFA,为竞争性及选择性血管活性肠肽(VIP)受体拮抗剂,其IC50为125.8 nM。该化合物针对胰高血糖素、促胰液素和GRF受体均不表现活性。 | |||
TP1989 |
NEP(1-40)
Nogo-66 (1-40) |
||
Peptide fragment corresponding to residues 1 - 40 of Nogo-66, the domain of the myelin protein Nogo that inhibits axonal outgrowth. Acts as a competitive antagonist at the Nogo-66 receptor (NgR); blocks Nogo-66- and CNS myelin-induced inhibition of axonal | |||
T75739 |
PKI(5-24) TFA
|
||
PKI(5-24) TFA 是一种强效、竞争性、合成的PKA(cAMP 依赖性蛋白激酶) 抑制剂,Ki 为 2.3 nM。PKI(5-24) TFA 对应于天然存在的热稳定蛋白激酶抑制剂中的 5-24 残基。 | |||
T75765 |
GRGDSPK TFA
|
||
GRGDSPK TFA (EMD 56574 TFA) 是一种含有精氨酸-甘氨酸-天冬氨酸 (RGD) 序列的多肽。作为竞争性且可逆的抑制剂,它能够抑制整联蛋白与纤连蛋白的结合,用于探究整联蛋白在骨形成及吸收过程中的功能。 | |||
T80516 |
human GALP (3-32)
Galanin-like peptide (3-32) |
Neuropeptide Y Receptor | GPCR/G Protein; Neuroscience |
Human GALP (3-32) (Galanin-like peptide (3-32)) 是一种高效的galanin receptor激动剂。在竞争性结合实验中,该化合物对GalR1 (IC50=33 nM) 及GalR2 (IC50=15 nM) 表现出强烈亲和力。此外,human GALP (3-32) 显著增加了转染GalR2 (EC50=360 nM) 的 SH-SY5Y细胞的胞外酸化速率。 | |||
T75895 |
UFP-101 TFA
|
||
UFP-101 TFA 是一种强效、选择性和竞争性的 NOP 受体拮抗剂,pKi 为 10.24。UFP-101 TFA 对 δ、μ 和 κ 类阿片受体的选择性大于 3000 倍。UFP-101 TFA 具有抗抑郁药样作用。 | |||
T80253 |
S3 Fragment
|
||
S3 Fragment 是具有生物活性的肽,含有 ADF/cofilin 的特异性 N-端磷酸化位点,即 LIM 激酶(LIMK)的靶点。LIMK1 通过在 ADF/cofilin 的丝氨酸 3 位磷酸化来失活该蛋白,是肌动蛋白细胞骨架重要调控因子。该肽段包含 ADF/cofilin 丝氨酸 3 位点,作为 LIMK1 的有效竞争性抑制剂而被广泛研究。 | |||
T80175 |
Conopeptide rho-TIA
|
Adrenergic Receptor | GPCR/G Protein; Neuroscience |
Conopeptide rho-TIA为从掠食性海螺Conus tulipa毒液中提炼的多肽,对人类α1B-Adrenergic Receptor呈现非竞争性抑制作用,同时对α1A-Adrenergic Receptor和α1D-Adrenergic Receptor表现出竞争性抑制。Conopeptide rho-TIA与这些亚型的结合特性可能对开发针对α1-Adrenergic Receptor亚型的选择性新药具有参考价值。 | |||
T75810 |
AKTide-2T TFA
|
||
AKTide-2T TFA 是一个优良的体外AKT 底物,可竞争性抑制组蛋白 H2B 磷酸化,其Ki 值为 12 nM。AKTide-2T TFA 模拟Akt 的磷酸化序列,是一种抑制肽,是 S22 位置中缺失了野生型 AKTide。 | |||
T75832 |
Cyclotraxin B TFA
|
||
Cyclotraxin B TFA 是一种环肽,是一种高效且选择性的 TrkB 抑制剂,且不会改变 BDNF 的结合。Cyclotraxin B TFA 非竞争性地抑制 BDNF 诱导的 TrkB 活性,IC50值为 0.30 nM。Cyclotraxin B TFA 可以穿越血脑屏障,并具有止痛和抗焦虑的行为作用。 | |||
T80167 |
αC-Conotoxin PrXA
αC-PrXA |
||
αC-Conotoxin PrXA为麻痹肽类神经毒素,亦是竞争性nAChR拮抗剂,对α1β1εδ(成人型)和α1β1γδ(胎儿型)nAChR的IC50值分别为1.8 nM和3.0 nM。该化合物通过与α-bungarotoxin竞争nAChR的α/δ及α/γ亚基界面,展现出对神经肌肉型nAChR的高度特异性。 | |||
T69383 |
NBI-42902
|
||
NBI-42902 is a potent inhibitor of peptide radioligand binding to the human GnRH receptor (K(i) = 0.56 nm). Tritiated NBI-42902 binds with high affinity (K(d) = 0.19 nm) to a single class of binding sites and can be displaced by a range of peptide and nonpeptide GnRH receptor ligands. In vitro experiments demonstrate that NBI-42902 is a potent functional, competitive antagonist of GnRH stimulated IP accumulation, Ca(2+) flux, and ERK1/2 activation. It did not stimulate histamine release from rat... | |||
T80166 |
α-Conotoxin BuIA
|
||
α-Conotoxin BuIA 是一种麻痹性肽类神经毒素,同时也是竞争性nAChR拮抗剂。它对nAChR亚型表现出不同的IC50值:0.258 nM(α6/α3β2)、1.54 nM(α6/α3β4)、5.72 nM(α3β2)。该化合物可用于鉴别包含β2与β4亚单位的nAChR亚型。此外,α-Conotoxin BuIA 对αxβ2nAChR的区分能力按照α6>α3>α2>α4的顺序减弱。 | |||
T76213 |
HXR9 hydrochloride
|
||
HXR9 hydrochloride 是一种针对 HOX/PBX 相互作用的细胞渗透性肽类竞争性拮抗剂。它通过阻碍 HOX 蛋白与 PBX,一个与旁系同源基因组 1 至 8 结合的第二转录因子,之间的相互作用来发挥作用。特别地,HXR9 hydrochloride 能够选择性抑制细胞增殖,并在表达 HOXA/PBX3 基因高水平的细胞中,如 MLL 重排的白血病细胞,促进细胞凋亡。 | |||
T75715 |
Nonapeptide-1 acetate salt
|
||
Nonapeptide-1 (Melanostatine-5) acetate salt,一种多肽类激素,是 MC1R 选择性拮抗剂 (Ki: 40 nM)。 Nonapeptide-1 acetate salt 是一种竞争性的α-MSH 拮抗剂,可有效抑制黑素细胞中 α-MSH 诱导的细胞内 cAMP 和黑素体扩散 (IC50分别为 2.5 nM 和 11 nM)。 Nonapeptide-1 acetate salt 抑制黑色素合成,可用于研究皮肤色素沉着和肾上腺类固醇生成的调节、皮肤癌。 | |||
T78224 |
Histatin-3
|
||
Histatin-3是一肽类物质,由32个氨基酸残基构成,表现出显著的抗菌活性。作为前蛋白转化酶1(PC1)的底物,Histatin-3在Arg25位点的羧基端被该蛋白酶特异性切割(HRGYR降低SN)。此外,Histatin-3亦作为中等效力的、可逆的以及具竞争性的抑制剂,能够抑制弗林蛋白酶介导的五肽pGlu-Arg-Thr-Lys-Arg-MCA荧光底物的裂解,其抑制常数Ki大约为1.98μM。 | |||
T37522 | Teneligliptin | ||
Teneligliptin (MP-513) is a potent chemotype prolylthiazolidine-based DPP-4 inhibitor, which competitively inhibits human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC50s of approximately 1 nM. Teneligliptin (MP-513) inhibits all these DPP-4 enzymes in a concentration-dependent manner. The IC50s of Teneligliptin (MP-513) for rhDPP-4, human plasma, and rat plasma are 0.889, 1.75, and 1.35 nM, respectively. A study of enzyme inhibition kinetics is conducted for Teneligliptin (M... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T75890 |
Conantokin G TFA
|
||
Conantokin G TFA 是一种 17 个氨基酸的肽,是一种有效,选择性和竞争性的 N-甲基-D-天冬氨酸 (NMDA) 受体拮抗剂。Conantokin G TFA 抑制鼠皮质神经元中NMDA 诱发的电流,IC50为 480 nM,具有神经保护作用。 |